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the purpose of this study was to evaluate risk factors of Clostridium Difficile infection (cDi) after 
spinal surgery using the Health insurance Review and Assessment Service (HiRA) data. the incidence 
of postoperative CDI was investigated using HIRA data from 2012 to 2016. Cases involving CDI that 
occurred within a 30-day postoperative period were identified. Risk factors, including age, sex, 
comorbidities, postoperative infection, spinal surgery procedure, type of antibiotic, and duration 
of antibiotic use, were evaluated. Duration of hospital stay, medical cost, and mortality were also 
evaluated. In total, 71,322 patients were included. Presumed cases of CDI were identified in 57 patients, 
with CDI rate of 0.54 per 10,000 patient days. Advanced age, staged operation, postoperative infection, 
and the use of multiple antibiotics were significant risk factors. First-generation cephalosporins were 
shown to be associated with a lower incidence of cDi. cDi was also associated with longer hospital 
stays and increased medical cost, and it was an independent risk factor for increased mortality. 
Extra attention should be paid to patients at high risk for the development of postoperative CDI, and 
unnecessary use of multiple antibiotics should be avoided. Level of Evidence: Level III, retrospective 
cohort study
Clostridium difficile (C. difficile) is a common pathogen responsible for approximately 10 to 25% of all cases of 
antibiotic-associated diarrhea1. C. difficile infection (CDI) can occasionally lead to life-threatening complica-
tions, such as pseudomembranous colitis, intestinal perforation, and toxic megacolon2. The incidence of CDI is 
increasing globally, and more than 1.1 billion dollars have been devoted to the treatment of CDI in the United 
States alone3.
Spinal surgery is one of the most frequently performed surgeries worldwide, and the number of spinal surger-
ies continues to increase annually4, as are the rate of complex procedures and the age of spinal surgery patients5. 
Since operative mortality and morbidity increase with increasing age and surgical invasiveness, interest in the 
prevention of postoperative complications has grown. Several studies have reported on CDI after spinal surgery, 
which can be fatal6–8. However, because of the low incidence of CDI, previous studies focused on the incidence 
and demographic risk factors of patients. There has not yet been a study on the effect of medication use on the 
development of CDI after spinal surgery, although it is well known that some types of antibiotics and gastric 
acid-suppressive medications are associated with CDI.9
In the presence of known risk factors of CDI, the prolonged use of antibiotics and broad-spectrum antibiotics 
could increase the incidence of CDI. Therefore, the aim of this study was to identify the incidence of CDI after 
spinal surgery; risk factors thereof, including the type and duration of antibiotics use; and the effect of CDI on 
surgical outcomes using a large, population-based, nationally representative sample.
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Results
Of 71,322 patients, 57 were diagnosed with CDI within 30 days after surgery (incidence 0.08%). The CDI rate per 
total number of patient days was 0.54 per 10,000 patient days. The average time from surgery to CDI diagnosis 
was 18.16 ± 7.81 days. Lumbar surgery (80.68%) was the most common procedure, and the incidence of CDI 
therein was 0.07%. The percentage of other procedures are detailed in Table 1.
Patients who acquired postoperative CDI after spinal surgery were significantly older (67.12 ± 10.94 vs. 
57.27 ± 14.78); there was no difference in sex (Table 2). The proportion of patients over 65 years of age was greater 
in the CDI group than in the non-CDI group (P < 0.001). CDI patients also had a higher prevalence of chronic 
obstructive pulmonary disease (P = 0.030) and a higher incidence of postoperative infection, such as urinary tract 
infection (P < 0.001), sepsis (P < 0.001), or pneumonia (P < 0.001), compared to patients without CDI. Patients 
with CDI were more likely to have been prescribed proton pump inhibitors postoperatively (P = 0.002); however, 
there was no significant difference in the use of H2 blockers between the CDI and non-CDI groups. As for the use 
of antibiotics, broad spectrum antibiotics were more often prescribed to CDI patients, including third generation 
cephalosporins (P < 0.001), fourth generation cephalosporins (P = 0.013), penicillins (P < 0.001), glycopeptides 
(P < 0.001), carbapenems (P = 0.009), and ketolides (P = 0.043). On the other hand, CDI patients were less likely 
to be given first generation cephalosporins (P = 0.004).
The effect of the duration of antibiotics use and the number of co-administered antibiotics on the incidence 
of CDI was investigated. (Table 3) The higher the number of administered antibiotics, the higher the incidence of 
CDI (P < 0.001). There was no significant difference according to the duration of antibiotics used.
In multivariate analysis, independent preoperative/postoperative risk factors for postoperative CDI included 
greater age (most notably ≥65 years old, OR = 6.408, 95% confidence interval (CI) = 1.521–26.997, P = 0.011), 
staged operation (OR = 5.336, 95% CI = 1.417–20.087, P = 0.013), postoperative infection such as urinary tract 
infection (OR = 3.538, 95% CI = 1.698–7.371, P = 0.001), sepsis (OR = 4.427, 95% CI = 2.458–7.975, P < 0.001), 
and pneumonia (OR = 6.096, 95% CI = 2.793–13.303, P < 0.001) (Table 4). First-generation cephalosporins 
(OR = 0.408, 95% CI = 0.226–0.738, P = 0.003) were associated with a lower incidence of CDI. The use of three 
or more antibiotics was associated with higher CDI incidence (OR = 2.808, 95% CI = 1.266–6.229, P = 0.011). 
Third- and fourth-generation cephalosporins, penicillins, glycopeptides, carbapenems, and ketolides, which pre-
viously were shown to be associated with increased incidence of CDI, were not identified as significant risk factors 
for CDI in the multivariate model. The duration of antibiotics used also did not have a significant effect.
Postoperative CDI after spinal surgery resulted in remarkably negative outcomes. Mean hospitalization 
period increased more than three-fold for patients diagnosed with CDI versus. those not diagnosed with CDI 
(64.91 ± 74.87 days vs. 18.85 ± 25.37 days, P < 0.001). When multiple regression analysis was performed to inves-
tigate risk factors for increased hospitalization period, CDI increased the hospitalization period increased by 
30.12 days (P < 0.001) after adjusting for other variables. The total medical cost increased by more than four-fold 
for those patients with CDI diagnosis ($14,704 ± 15,590 vs. $3,580 ± 4,190, P < 0.001).
Multivariate analyses, identifying independent risk factors for mortality within 30 days postoperatively, iden-
tified CDI as a significant risk factor (OR = 7.717, 95% CI = 1.670–35.662, P = 0.009) (Table 5). In addition, the 
use of antibiotics, such as fourth-generation cephalosporins, penicillins, glycopeptides, and carbapenems, were 
associated with significantly increased odds of death, whereas the first- and second-generation cephalosporins 
were associated with lower risk. Advanced age and the use of three or more antibiotics were also associated with 
an increased odds of death.
Discussion
In this study, we found CDI after spinal surgery to be associated with advanced age, staged operation, postop-
erative infection, and administration of three or more antibiotics. The third-generation cephalosporins, clin-
damycins, penicillins, and fluoroquinolones were previously reported as risk factors for CDI10,11. In this study, 
first-generation cephalosporins were associated with a low incidence of CDI in the multivariate analysis, whereas 
the third- and fourth-generation cephaslosporins, penicillins, glycopeptides, carbapenems, and ketolides were 
statistically significant risk factors in the univariate analysis alone. This may be due to the fact that, clinically, 
many patients are treated with more than one type of antibiotic perioperatively for broad coverage.
A previous study reported that more than 10 days of antibiotics were identified as a significant risk factor for 
CDI12; however, although higher CDI incidence was noted when antibiotics were administered for a longer period 
of time, the trend was not statistically significant in our study. The period of antibiotics use was calculated as the 
number of days the antibiotics administered regardless of the number of antibiotics used. However, antibiotic 
Procedures Total Cases, No. (%) CDI, No.
Incidence of 
CDI (%)
All spine surgical 
procedure 71,322 (100%) 57 0.08%
Cervical 9,179 (12.87%) 10 0.11%
Thoracic 1,282 (1.80%) 1 0.08%
Lumbar 59,541 (83.48%) 44 0.07%
Multilevel 1,320 (1.85%) 2 0.15%
Table 1. Incidence of Clostridium difficile infection according to spinal surgery procedure. CDI: Clostridium 
Difficile infection. Multilevel indicates the simultaneous operation of two or more of the cervical, thoracic, and 
lumbar regions.





Mean age 67.12 ± 10.94 57.27 ± 14.78 <0.001








   Hypertension 45.61% 37.95% 0.234
   Diabetes mellitus 28.07% 19.49% 0.102
   COPD 8.77% 3.06% 0.030
Stage operation 5.26% 0.24% <0.001
Postoperative infection
   Urinary tract infection 19.30% 2.37% <0.001
   Sepsis 33.33% 6.82% <0.001
   Pneumonia 19.30% 1.23% <0.001
   Surgical site infection 0.03% 1.75% 0.016
   Any infection 61.40% 25.27% <0.001
Additional postoperative 
prescription
   Proton pump inhibitor 29.82% 15.07% 0.002
   H2 blocker 89.46% 81.87% 0.136
   Lactobacillus 3.51% 1.50% 0.211
Antibiotic types
   1st generation 
cephalosporins 52.63% 70.26% 0.004
   2nd generation 
cephalosporins 49.12% 50.94% 0.784
   3rd generation 
cephalosporins 40.35% 15.86% <0.001
   4th generation 
cephalosporins 3.51% 0.30% 0.013
   Aminoglycosides 17.54% 12.67% 0.269
   Penicillins 22.81% 8.17% <0.001
   Quinolones 21.05% 13.32% 0.086
   Glycopeptides 22.81% 4.13% <0.001
   Carbapenems 5.26% 0.75% 0.009
   Ketolides 5.26% 1.37% 0.043
   Others 12.28% 1.80% <0.001
Table 2. Patient characteristics, comorbidities, and prescribed medications in, with, and without Clostridium 
difficile infection. CDI: Clostridium difficile infection; COPD: Chronic obstructive pulmonary disease.
Total Cases, No. (%) CDI, No.
Incidence 
of CDI (%) P Value
†Duration of 
antibiotic use (day) 0.201
   7 or less 44802 (62.8%) 31 0.07
   8 ~ 14 21709 (30.4%) 21 0.10
   15 or more 4811 (6.7%) 5 0.10
Number of 
antibiotics <0.001
   1 32047 (44.9%) 14 0.04
   2 26122 (36.7%) 19 0.07
   3 or more 13123 (18.4%) 24 0.18
Table 3. Clostridium difficile infection incidence according to the duration of antibiotic use and the number of 
administered antibiotics. CDI: Clostridium difficile infection †The duration of antibiotic use was calculated as the days 
which the antibiotics were administered, regardless of the number of antibiotics or the route of administration.
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days was defined as the summation of the number of days of administration of each antibiotic in the previous 
study12. The difference in the definition of the duration of antibiotic administration may have resulted in such 
disparity.
Multiple studies have reported on the risk of perioperative antibiotic prophylaxis and CDI. Prophylactic mon-
otherapy with cefoxitin (second generation cephalosporin) was associated with a higher risk of CDI, and the 
addition of another antibacterial to cefoxitin further increased the risk13. The use of multiple antibiotics rather 







95% CI *P value
Age, years
   ≤45 Ref.
   45–65 4.526 1.061 19.312 0.041*
   >65 6.408 1.521 26.997 0.011*
   Staged Operation 5.336 1.417 20.087 0.013*
Postoperative infection
   Any infection 3.215 1.849 5.589 <0.001*
   UTI 3.538 1.698 7.371 0.001*
   Sepsis 4.427 2.458 7.975 <0.001*
   Pneumonia 6.096 2.793 13.303 <0.001*
Type of Antibiotics
   1st generation 
Cephalosporin 0.408 0.226 0.738 0.003*
   2nd generation 
Cephalosporin 0.600 0.328 1.095 0.096
   Quinolone 0.379 0.180 0.796 0.010*
Number of Antibiotics
   1 Ref.
   2 2.010 0.976 4.140 0.058
   3 or more 2.808 1.266 6.229 0.011*
Table 4. Independent risk factors for postoperative Clostridium difficile infection. CI: Confidence Intervals; 







95% CI P value
CDI 7.717 1.670 35.662 0.009*
Age, years
   ≤45 Ref.
   45–65 1.925 1.008 3.677 0.047*
   >65 2.809 1.489 5.299 0.001*
Postoperative infection
   Any infection 
excluding CDI 0.660 0.440 0.988 0.044*
   Pneumonia 2.939 1.786 4.837 <0.001*
Type of Antibiotics
   1st generation 
cephalosporins 0.638 0.424 0.959 0.031*
   2nd generation 
cephalosporins 0.597 0.394 0.904 0.015*
   4th generation 
cephalosporins 2.910 1.483 5.707 0.002*
   Penicillins 2.813 1.838 4.306 <0.001*
   Glycopeptides 2.051 1.288 3.267 0.002*
   Cabapenems 1.878 1.089 3.238 0.023*
Number of antibiotics
   1 Ref.
   2 1.458 0.816 2.604 0.202
   3 or more 3.016 1.648 5.519 <0.001*
Table 5. Independent risk factors for postoperative mortality within 30 days after surgery. CI: Confidence 
Intervals; CDI: Clostridium Difficile infection. *Significant P values < 0.05. R2 = 0.284.
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of antibiotics was associated with an increased risk of CDI after spinal surgery. The Surgical Infection Society 
Guidelines on surgical prophylaxis recommend the use of antimicrobial prophylaxis for spinal procedures with 
or without instrumentation15. They also recommend monotherapy with cefazolin, either used as a single dose or 
administered up to 24 hours postoperatively15. Clindamycin and vancomycin could be used instead for patients 
with beta-lactam allergies. None of these antibiotics was associated with an increased risk of CDI in the present 
study, and therefore, these antibiotics could safely be used for prevention of both surgical site infection and CDI.
Although the surgical antibiotic prophylaxis recommends monotherapy with first-generation cephalosporin, 
other types of antibiotics or multiple drugs were prescribed perioperatively. We identified that prophylactic anti-
biotics were prescribed in combination in 21% of patients on the day of surgery. Among patients without any 
postoperative infection, only 30.5% was administered first-generation cephalosporins alone for surgical antibi-
otic prophylaxis. The second-generation cephalosporins were used as prophylactic antibiotics in many patients 
(15.3%), and many hospitals prescribed second-generation cephalosporins as discharge medication after intra-
venous administration of first-generation cephalosporins (18.2%). Similar pattern of such misuse of antibiotics 
was previously addressed in 2012 HIRA report on the adherence of surgical prophylaxis protocol. Combination 
of antibiotics was given to 19.8% of surgical patients, and 16.4% was given antibiotics as discharge medication16.
Similar to the results of the previously published papers on CDI after spinal surgery, we identified advanced 
age and postoperative infection, including urinary tract infection, as significant risk factors6–8. The difference 
from the previous studies is that we were able to identify antibiotic regimens and other perioperative medications. 
We demonstrated that the use of multiple antibiotics was a more significant risk factor than type of antibiotics and 
duration of use. There is a controversy regarding whether antacids increase the risk of CDI17. Although proton 
pump inhibitors were not shown to be associated with increased risk in the multivariate analysis, they were more 
commonly prescribed in the CDI patients. Therefore, caution should be taken when prescribing proton pump 
inhibitors to patients with an increased risk of CDI.
A novel finding in this study was that staged operations were shown to be an independent risk factor for 
CDI. Staged operation accounted for 0.2% of the cases, and it was associated with 5.336 times higher risk of CDI. 
Recently, the number of adult spinal deformity surgeries is rapidly increasing, and circumferential spine fusion 
is performed frequently18,19. Because these procedures are complex and the prolonged operation time poses sig-
nificant burden on the patients, the surgeries are often performed in a staged manner20. Therefore, patients who 
receive staged operations may need more meticulous patient care and monitoring for development of postoper-
ative complications, including CDI. Also, unlike in previous reports on CDI after spinal surgery, we subdivided 
postoperative infection into any infection, urinary tract infection, sepsis and pneumonia, and confirmed that all 
types of postoperative infection were risk factors for CDI.
Many studies have reported that CDI increases the length of hospitalization, medical cost, and mortality6,21. 
Similarly, we found that CDI increased mortality rate after spinal surgery by more than seven-fold, and CDI was 
associated with increased hospital stay and escalated treatment costs. The global surge in the incidence of hyper-
virulent C. difficile 027/BI/NAP1 subtype is likely to produce a significant burden on the health care system in the 
near future13,22.
The incidence of CDI after spinal surgery has been reported as 0.08–0.11%6–8. Our study found that the CDI 
incidence within 30 days after spinal surgery was 0.08%, which was lower than previous results. This disparity 
may be due to the difference in the definition of CDI. We identified CDI cases as those that satisfied both criteria 
of a specific diagnostic code and specific antibiotic administration, whereas other studies identified patients with 
the diagnoses alone6,8, or selected patients based on their medical record7.
There are several limitations in our study. We used administrative data and were unable to review the medical 
records for confirmation of the diagnosis or the treatment. The insurance claim data did not include individ-
ual health and nutritional status, such as body mass index, functional status, or smoking status, and it also did 
not provide laboratory data, such as hypoalbuminemia. Therefore, the severity or the stage of the conditions 
could not be investigated. Another inherent limitation of HIRA data is that there could be discordance between 
the diagnoses entered in the system and the actual health status of the patient, especially for mild conditions. 
Therefore, we could not calculate the comorbidity index and analyze its association with the CDI incidence. 
HIRA-NIS data includes insurance claim data of 13% of randomly selected inpatients, and each sample is labeled 
with an allocation number. The sample is renewed annually, and since the data is anonymous, a single patient who 
received operations more than once in different years may be classified as multiple different samples. Although 
we excluded surgery due to infection, we did not distinguish between trauma, degenerative disease, and con-
genital deformity. We also could not identify emergency surgeries. Furthermore, even though this study inves-
tigated 71,322 patients undergoing spinal surgery, the absolute number of patients (n = 57) with CDI was still 
low. Finally, our study restricted CDIs to those that occurred within 30 days after spinal surgery. Although many 
previous studies also used the same definition6–8, CDI has also been reported to occur after more than 30 days 
after antibiotics administration23.
In conclusion, we found that advanced age, staged operation, postoperative infection, and the use of multiple 
antibiotics were independent risk factors for CDI after spinal surgery. Although the incidence was low (0.08%), 
CDI was associated with negative outcomes of increased hospital stay, increased medical cost, and increased mor-
tality. Therefore, modifiable risk factors should be minimized in order to prevent CDI and to optimize surgical 
outcome after spinal surgery. In particular, the unnecessary use of multiple antibiotics should be avoided.
Methods
Database and data collection. The National Health Insurance (NIH) covers about 98% of the South 
Korean population24. The data of the Health Insurance Review and Assessment Service (HIRA) includes infor-
mation on patient diagnoses, past medical or surgical history, treatment procedures, and prescription dispensing 
information. We used the National Inpatient Sample of the HIRA (HIRA-NIS), which contains claims data of 13% 
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of randomly selected inpatients. Data of patients who underwent spinal surgery from 2012 to 2016 were collected; 
those with spinal infections were excluded. Of the 71,761 patients, 293 patients were excluded due to spine-related 
infections and 146 patients were excluded from other types of infections.
The procedural codes of spinal surgery used in this study are described in Table 6. Outpatient based proce-
dures such as vertebroplasty, kyphoplasty, neuroplasty and nerve block were excluded.
Presumed surgery-related CDI patients were identified as those diagnosed with enterocolitis due to C. difficile 
(International Classification of Diseases, Tenth Revision [ICD-10], diagnosis code A04.7.) and required adminis-
tration of drugs used for CDI, such as metronidazole or vancomycin, within 30 days of spinal surgery.
Because HIRA-NIS data is a random sample and the sample population is renewed every year, we excluded 
patients who had surgery in December of each year for whom 30-day follow-up was not possible. According to 
the data from 2001 to 2010 in the United States, the incidence of CDI was highest in spring and lowest in autumn; 
therefore, excluding the data for December was unlikely to have a significant impact on the outcomes of our 
study25.
Patients were categorized into two groups: C. difficile infected and non-infected. Risk factors, such as age, sex, 
comorbidities, postoperative infection, spinal surgery procedure, staged operation, the types of antibiotics, and 
the duration of antibiotic use, were evaluated. Patients were presumed to have received staged operation if they 
received operation of the same site on different days, no more than 2 weeks apart, of the same hospitalization. The 
duration of the hospital stay, medical cost, and mortality were also evaluated.
This study was approved by the Institutional Review Board of Severance Hospital. Informed consent of the 
patients was waived since the study involved a retrospective access to publicly available and anonymized data. All 
methods were carried out in accordance with relevant guidelines and regulations.
Statistical Analysis. Statistical analysis was performed by independent two-sample t-test and chi-square (or 
Fisher’s exact) test. For continuous variables, the data are expressed as a mean ± standard deviation. For categori-
cal variables, the data are expressed as counts and percentages. To assess potential risk factors for CDI after spinal 
surgery, a multivariable logistic regression model was created to assess for multivariable predictors of CDI after 
spinal surgery. A multivariable logistic regression model was also constructed for mortality. Results are reported 
as odds ratio (OR) and 95% CIs. Risk factors associated with CDI diagnosis were assessed using multivariable 
logistic regression including all variables. The Hosmer-Lemeshow and model Χ2 goodness of fit tests were used 
for the model. All statistical analyses were performed with IBM SPSS Statistics for Windows/Macintosh, Version 
23.0 (IBM Corp., Armonk, NY, USA). P values < 0.05 were considered significant.
Data availability





N2491, N2492 Cervical Spine Laminoplasty
N1497, N2497 Laminectomy, Cervical Spine
N1498, N2498 Laminectomy, Thoracic Spine
N1499, N2499 Laminectomy, Lumbar Spine
N0466, N1466 Arthrodesis of Spine-Lumbar Spine-Anterior Technique
N0468, N1469 Arthrodesis of Spine-Thoracic Spine-Posterior Technique
N0469 Arthrodesis of Spine-Lumbar Spine-Posterior Technique
N1460, N2470 Posterior Lumbar Interbody Fusion
N2461, N2463 Arthrodesis of Spine-Cervical Spine-Anterior Technique
N2464, N2465, N2466 Arthrodesis of Spine-Thoracic Spine-Anterior Technique
N2467, N2468, N2469 Arthrodesis of Spine-Cervical Spine-Posterior Technique
N0451 Vertebral Corpectomy (Cervical Spine)
N0452 Vertebral Corpectomy (Thoracic Spine)
N0453 Vertebral Corpectomy (Lumbar Spine)
N0444, N0445 Arthrodesis for Spinal Deformity (Anterior Technique)
N0446, N0447 Arthrodesis for Spinal Deformity (Posterior Technique)
N0303 Osteotomy (Spine, Pelvis)
Table 6. Korea Informative Classification of Diseases procedural codes of spinal surgeries included in the study.
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